Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albigès, Fabrice Barlési, Fanny Pommeret et al.|Nature Cancer|2020Cited by 119
Results of the LMT81 protocol, a modified LSA<sub>2</sub>L<sub>2</sub> protocol with high dose methotrexate, on 84 children with non‐B‐cell (lymphoblastic) lymphomaCatherine Patte, Jean Lemerle, C Kalifa et al.|Medical and Pediatric Oncology|1992Cited by 113